Serodiagnosis of mycobacterium avium-complex pulmonary disease using anti-glycopeptidolipid core antigen IgA antibody

Y. Kamiya, Y. Amano, Y. Aoshima, T. Uto, S. Sagisaka, J. Sato, S. Imokawa, K. Yasuda, T. Suda, K. Chida (Iwata, Hamamatsu, Japan)

Source: Annual Congress 2013 –Difficult and rare respiratory infections
Session: Difficult and rare respiratory infections
Session type: Poster Discussion
Number: 2076
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Kamiya, Y. Amano, Y. Aoshima, T. Uto, S. Sagisaka, J. Sato, S. Imokawa, K. Yasuda, T. Suda, K. Chida (Iwata, Hamamatsu, Japan). Serodiagnosis of mycobacterium avium-complex pulmonary disease using anti-glycopeptidolipid core antigen IgA antibody. Eur Respir J 2013; 42: Suppl. 57, 2076

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical evaluation of glycopeptidolipid core antigen IgA antibodies for serodiagnosis of mycobacterium avium complex pulmonary disease
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

Usefulness of serum glycopeptidolipid core immunoglobulin A antibody in mycobacterium avium complex infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Clinical evaluation of glycopeptidolipid core antigen IgA antibodies for serodiagnosis of mycobacterium avium complex disease
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Usefulness of serum anti-glycopeptidolipid core IgA antibody assay for the diagnosis of pulmonary infection of mycobacterium avium complex
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Clinical nalysis of glycopeptidolipid core antigen IgA antibodies for cases in which it is difficult to obtain a definite diagnosis of mycobacterium avium complex pulmonary disease
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Retrospective investigation of patients positive for glycopeptidolipid-core antibody to mycobacterium avium complex pulmonary disease
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Nontuberculous mycobacterial lung disease caused by Mycobacterium parascrofulaceum in an immunocompetent patient
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosis
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015

Pulmonary mycobacterium xenopi infection in Japan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Clinical relevance of Mycobacterium simiae in pulmonary samples
Source: Eur Respir J 2008; 31: 106-109
Year: 2008



Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Development of a prognostic scoring system for Mycobacterium avium complex lung disease
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016


Pulmonary non-tuberculous mycobacterial infection (pNTM) with multiple species
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013

Characteristics of patients with isolation of mycobacterium xenopi
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Late Breaking Abstract - Use of non-tuberculous mycobacteria (NTM) specific antigens to detect NTM infection
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019




Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Intracellular ESAT-6 vs flow cytometric analysis of CD4+IFN-γ+ cells for the diagnosis of mycobacterium tuberculosis infection in immunosuppressed patients
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Clinical importance of pulmonary nontuberculous mycobacteria isolated among HIV-positive individuals in Ghana
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015